These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The perilous path to a better measles vaccine. Minor PD CVI Forum; 1992 Oct; (2):8-10. PubMed ID: 12321775 [TBL] [Abstract][Full Text] [Related]
3. Birth control vaccines. Basten A Baillieres Clin Immunol Allergy; 1988 Oct; 2(3):759-74. PubMed ID: 12342688 [TBL] [Abstract][Full Text] [Related]
4. A Forum brief on nucleic acid vaccines. CVI Forum; 1994 Aug; (7):7-10. PubMed ID: 12294222 [TBL] [Abstract][Full Text] [Related]
5. Active and passive immunity, vaccine types, excipients and licensing. Baxter D Occup Med (Lond); 2007 Dec; 57(8):552-6. PubMed ID: 18045976 [TBL] [Abstract][Full Text] [Related]
6. [Egoistic vaccines. Altruistic vaccines]. Reinert P Dev Sante; 1998 Jun; (135):3. PubMed ID: 12321849 [TBL] [Abstract][Full Text] [Related]
7. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. America Academy of Pediatrics Commitee on Infectious Diseases Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131 [TBL] [Abstract][Full Text] [Related]
8. A Forum guide to mucosal immunization. CVI Forum; 1994 Apr; (6):2-3. PubMed ID: 12321776 [TBL] [Abstract][Full Text] [Related]
9. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
10. An immunization program for dental practices. Palenik CJ; Govoni M Compend Contin Educ Dent; 2004 Jan; 25(1 Suppl):17-22. PubMed ID: 15641330 [TBL] [Abstract][Full Text] [Related]
11. HIV vaccine update. DNA vaccination: a promising candidate for a vaccine against HIV-1? Van Der Ryst E TB HIV; 1996; (11):15-8. PubMed ID: 12179800 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of tuberculosis in children. Chaulet P Child Trop; 1992; (196-197):7-19. PubMed ID: 12345144 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216 [TBL] [Abstract][Full Text] [Related]
14. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348 [TBL] [Abstract][Full Text] [Related]
15. Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity. Lavine CL; Clinton SR; Angelova-Fischer I; Marion TN; Bina XR; Bina JE; Whitt MA; Miller MA Eur J Immunol; 2007 Nov; 37(11):3007-20. PubMed ID: 17960662 [TBL] [Abstract][Full Text] [Related]
16. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction. Mills KH Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777 [TBL] [Abstract][Full Text] [Related]
17. The standardization of Cl. perfringens antigens and antisera. Jansen BC Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510 [TBL] [Abstract][Full Text] [Related]
18. [Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine]. Ma FB; Zheng L; Bi C; Tao H; Zhou YL; Zhang JL; Tang FY; Xie P; Zheng CZ; Peng WB; Jiang RJ Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):113-5. PubMed ID: 12697111 [TBL] [Abstract][Full Text] [Related]
19. Immunopathology of RSV infection: prospects for developing vaccines without this complication. van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293 [TBL] [Abstract][Full Text] [Related]